Last reviewed · How we verify

NCT03738436

Adding Modified Visual Feedback Training in Patients Following ACL Reconstruction

Status unknown NA Last updated 8 November 2022
What this trial tests

NA trial testing Physical therapy traditional neuromuscular training, NMT in Anterior Cruciate Ligament Reconstruction in 40 participants. Status unknown.

Timeline
2 August 2019
Primary endpoint
15 March 2023
31 July 2023

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date2 August 2019
Primary completion15 March 2023
Estimated completion31 July 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

Adults 20 to 45, male only, with Anterior Cruciate Ligament Reconstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current treatment for the ACL-injured patients usually emphasize on the movement quality through neuromuscular training. The purpose of this study is to (1) design a modified visual feedback training program and (2) investigate the effects of the modified visual feedback training on the movement control in the ACL-reconstructed (ACL-R) patients. Forty unilateral ACL-R male patients will be enrolled voluntarily, who will be randomly allocated into the traditional neuromuscular training (NMT) or the modified visual feedback (MVF) group. The investigators hypothesize that this MVF training program will have better potential to improve their post-injury movement dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Reconstruction

Currently open trials in the same condition.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03738436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing